BridgeBio Pharma (NASDAQ:BBIO) Stock Quotes, Forecast and News Summary

BridgeBio Pharma Stock (NASDAQ: BBIO) stock price, news, charts, stock research, profile.

Open$28.81
Close$27.19
Volume / Avg.14.34M / 2.07M
Day Range$26.86 - $30.51
52 Wk Range21.62 - 44.32
Market Cap$5.16B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
62
Short Interest
13.97%
Days to Cover13.56

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jul
5
Aug
8
Sep
3
Oct
2
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$28.81
Close$27.19
Volume / Avg.14.34M / 2.07M
Day Range$26.86 - $30.51
52 Wk Range21.62 - 44.32
Market Cap$5.16B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
62
Short Interest
13.97%
Days to Cover13.56

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BBIO
IMVT

FAQ

Q

How do I buy BridgeBio Pharma (BBIO) stock?

A

You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BridgeBio Pharma (BBIO) competitors?

Q

What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?

A

BridgeBio Pharma has a consensus price target of $43.72.

Q

What is the current price for BridgeBio Pharma (BBIO)?

A

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $27.3 last updated November 25, 2024 at 4:37 PM EST.

Q

Does BridgeBio Pharma (BBIO) pay a dividend?

A

There are no upcoming dividends for BridgeBio Pharma.

Q

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

A

BridgeBio Pharma’s Q4 earnings are confirmed for Thursday, February 20, 2025.

Q

Is BridgeBio Pharma (BBIO) going to split?

A

There is no upcoming split for BridgeBio Pharma.

Q

What sector and industry does BridgeBio Pharma (BBIO) operate in?

A

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch